temoporfin has been researched along with aminolevulinic acid in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 10 (47.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mielcarek, J; Piskorz, J; Skupin-Mrugalska, P; Sobotta, L | 1 |
| Dougherty, TJ | 1 |
| Ash, DV; Brown, SB | 1 |
| DeJode, ML; Dilkes, MG; Gardiner, Q; Kenyon, GS; McKelvie, P | 1 |
| Bown, SG; Conio, M; MacRobert, AJ; Messmann, H; Millson, CE; Mĺkvy, P; Pauer, M; Regula, J | 1 |
| Jakober, R; Kostron, H; Obwegeser, A | 1 |
| Ell, C; Gossner, L; May, A; Sroka, R | 1 |
| Monnier, P; Radu, A; van den Bergh, H; Wagnières, G | 1 |
| Lilge, L; Portnoy, M; Wilson, BC | 1 |
| Bourré, L; Eléouet, S; Lajat, Y; Patrice, T; Rousset, N; Thibaut, S | 1 |
| Bentley, MV; Maillard, P; Souza, CS; Tedesco, AC; Turchiello, RF; Vena, FC | 1 |
| Eljamel, MS | 1 |
| Gross, SA; Wolfsen, HC | 1 |
| Allison, RR; Bagnato, VS; Sibata, CH | 1 |
| Berlanda, J; Engelhardt, V; Kiesslich, T; Krammer, B; Plaetzer, K | 1 |
| Davila, ML | 1 |
| Akram, S; Hamdoon, Z; Hopper, C; Jerjes, W; Mosse, CA; Upile, T | 1 |
| Dragicevic-Curic, N; Fahr, A | 1 |
| Rogers, GS | 1 |
| Brandal, G; Connelly, JM; Donlon, S; Foy, AB; Girotti, AW; Jogal, S; LaViolette, PS; Lew, SM; Mang, TS; Quirk, BJ; Vera, JC; Whelan, HT | 1 |
| Choudhary, MG; Gadbail, AR; Gondivkar, SM; Likhitkar, MS; Vedpathak, PR | 1 |
10 review(s) available for temoporfin and aminolevulinic acid
| Article | Year |
|---|---|
Porphyrinoid photosensitizers mediated photodynamic inactivation against bacteria.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Humans; Indoles; Isoindoles; Photochemotherapy; Photosensitizing Agents; Porphyrins | 2019 |
Photodynamic therapy.
Topics: Aminolevulinic Acid; Clinical Trials as Topic; Dihematoporphyrin Ether; Humans; Lasers; Mesoporphyrins; Neoplasms; Photochemotherapy; Photosensitizing Agents | 1993 |
Photodynamic therapy of early squamous cell cancers of the esophagus.
Topics: Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Squamous Cell; Dihematoporphyrin Ether; Drug Administration Routes; Esophageal Neoplasms; Esophagoscopy; Humans; Mesoporphyrins; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents | 2000 |
New light on the brain: The role of photosensitizing agents and laser light in the management of invasive intracranial tumors.
Topics: Aminolevulinic Acid; Brain Neoplasms; Clinical Trials as Topic; Dihematoporphyrin Ether; Glioma; Humans; Lasers; Mesoporphyrins; Necrosis; Photochemotherapy; Photosensitizing Agents; Prognosis | 2003 |
The role of photodynamic therapy in the esophagus.
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Dihematoporphyrin Ether; Esophageal Neoplasms; Humans; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents | 2010 |
Future of oncologic photodynamic therapy.
Topics: Aminolevulinic Acid; Dihematoporphyrin Ether; Forecasting; Humans; Mesoporphyrins; Nanoparticles; Neoplasms; Oxygen; Photochemotherapy; Photosensitizing Agents | 2010 |
Photodynamic therapy.
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Dihematoporphyrin Ether; Esophageal Neoplasms; Humans; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions | 2011 |
Liposomes in topical photodynamic therapy.
Topics: Aminolevulinic Acid; Drug Carriers; Humans; Light; Liposomes; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Skin Diseases | 2012 |
Photodynamic therapy (PDT) for malignant brain tumors--where do we stand?
Topics: Aminolevulinic Acid; Brain Neoplasms; Cell Death; Clinical Trials as Topic; Fluorescence; Hematoporphyrin Derivative; Humans; Infratentorial Neoplasms; Mesoporphyrins; Nitric Oxide; Photochemotherapy; Photosensitizing Agents; Porphyrins; Signal Transduction; Surgery, Computer-Assisted | 2015 |
Photodynamic treatment outcomes of potentially-malignant lesions and malignancies of the head and neck region: A systematic review.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Chlorophyllides; Databases, Factual; Dihematoporphyrin Ether; Erythroplasia; Head and Neck Neoplasms; Hematoporphyrins; Humans; Hyperplasia; Indoles; Laser Therapy; Lasers; Leukoplakia; Leukoplakia, Oral; Mesoporphyrins; Oral Submucous Fibrosis; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Porphyrins; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2018 |
2 trial(s) available for temoporfin and aminolevulinic acid
| Article | Year |
|---|---|
Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study.
Topics: Adult; Aged; Aminolevulinic Acid; Dihematoporphyrin Ether; Duodenal Neoplasms; Esophageal Neoplasms; Female; Gastrointestinal Neoplasms; Humans; Lasers; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Prodrugs; Protoporphyrins; Rectal Neoplasms | 1998 |
Photodynamic therapy outcome for oral dysplasia.
Topics: Aged; Aminolevulinic Acid; Carcinoma in Situ; Drug Administration Schedule; Female; Humans; Lasers, Semiconductor; Leukoplakia, Oral; Low-Level Light Therapy; Male; Mesoporphyrins; Middle Aged; Mouth Neoplasms; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Treatment Outcome | 2011 |
9 other study(ies) available for temoporfin and aminolevulinic acid
| Article | Year |
|---|---|
New drugs and future developments in photodynamic therapy.
Topics: Aminolevulinic Acid; Forecasting; Humans; Indoles; Isoindoles; Mesoporphyrins; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Porphyrins; Zinc Compounds | 1993 |
Treatment of head and neck cancer with photodynamic therapy: results after one year.
Topics: Aminolevulinic Acid; Antineoplastic Agents; Head and Neck Neoplasms; Hematoporphyrin Derivative; Humans; Mesoporphyrins; Photochemotherapy; Radiation-Sensitizing Agents; Treatment Outcome | 1995 |
Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model.
Topics: Aminolevulinic Acid; Animals; Brain; Brain Neoplasms; Carbon Radioisotopes; Disease Models, Animal; Female; Glioma; Mesoporphyrins; Photosensitizing Agents; Radionuclide Imaging; Rats | 1998 |
A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Barrett Esophagus; Biopsy; Carcinoma, Squamous Cell; Cardia; Catheterization; Drug Therapy, Combination; Endoscopy, Digestive System; Endosonography; Equipment Design; Esophageal Neoplasms; Female; Fiber Optic Technology; Follow-Up Studies; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Tomography, X-Ray Computed; Treatment Outcome | 1999 |
Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue.
Topics: Aminolevulinic Acid; Animals; Apoptosis; Brain; Brain Neoplasms; Dihematoporphyrin Ether; Indoles; Male; Mesoporphyrins; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Rabbits; Radiation-Sensitizing Agents | 2000 |
PDT effects of m-THPC and ALA, phototoxicity and apoptosis.
Topics: Aminolevulinic Acid; Animals; Apoptosis; Cell Survival; DNA Fragmentation; Light; Mesoporphyrins; Mice; Microscopy, Confocal; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Rats; Tumor Cells, Cultured | 2002 |
Cubic phase gel as a drug delivery system for topical application of 5-ALA, its ester derivatives and m-THPC in photodynamic therapy (PDT).
Topics: Administration, Topical; Aminolevulinic Acid; Drug Delivery Systems; Humans; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Prodrugs; Spectrometry, Fluorescence; Spectrophotometry | 2003 |
Comparative in vitro study on the characteristics of different photosensitizers employed in PDT.
Topics: Aminolevulinic Acid; Anthracenes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dihematoporphyrin Ether; Humans; Indoles; Mesoporphyrins; Organometallic Compounds; Perylene; Photochemotherapy; Photosensitizing Agents | 2010 |
Continuous low-irradiance photodynamic therapy: a new therapeutic paradigm.
Topics: Aminolevulinic Acid; Animals; Breast Neoplasms; Dihematoporphyrin Ether; Dose-Response Relationship, Radiation; Female; Humans; Light; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents | 2012 |